Weight-loss surgery dramatically outperformed GLP-1 medications in improving longevity and reducing heart, kidney, and eye ...

Figuring out how to lose weight and keep it off is a big challenge but a new study from the Cleveland Clinic details some ...

Researchers found that older adults with diabetes who took semaglutide—a medicine sold under the brand names Ozempic and ...

Semaglutide, tirzepatide, and other GLP-1 drugs appear to slow alcohol absorption and blunt its intoxicating effects, ...

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the ...

Eli Lilly stock dips after missing a priority voucher and price cut talks on rival obesity drugs. Read more here.

Novo Nordisk (NVO) stock is in focus as the company hires an executive from AbbVie (ABBV) as head of Corporate Affairs amid U ...

President Trump said he would lower the prices of popular weight-loss drugs, pressuring shares of drugmakers Novo Nordisk and ...

WeightWatchers has launched a first-of-its-kind solution that combines direct pricing from pharmaceutical manufacturers with flexible employer subsidy coverage for GLP-1 therapies for weight loss.

Shares of drugmakers Novo Nordisk and Eli Lilly fell Friday on concerns about pricing pressure after President Trump said the ...

CMS Administrator Mehmet Oz clarified that a deal has not yet been sealed with the manufacturer of semaglutide, Novo Nordisk, ...

Weight-loss drug stocks, including Novo Nordisk, Eli Lilly, Viking Therapeutics, Amgen, and Altimmune, face political scrutiny and market volatility following President Trump’s remarks on pricing ...